Product Information
KAITLIB FE 0.8-0.025 MG CHEW TB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.2925 per EA under NDC 68180090373. Its NADAC has been published 268 times since May 12, 2021.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180090373
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA203448On Market Since
2/7/2021
Price Statistics
The NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has been published 268 times since May 12, 2021, and over the history we have for it it has declined 42.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2925 per EA |
|---|---|
| All-time high | $2.6953 (Oct 13, 2021) |
| All-time low | $0.9745 (Feb 21, 2024) |
| 52-week high | $1.8990 |
| 52-week low | $1.2925 |
| Median price | $1.7314 |
| Average price | $1.6796 |
| Largest weekly change | +54.1% (Sep 22, 2021) |
| Weeks tracked | 268 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KAITLIB FE 0.8-0.025 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for KAITLIB FE 0.8-0.025 MG CHEW TB, manufactured by Lupin Pharmaceuticals Inc., is $1.2925 per EA (NDC 68180090373), effective Jun 24, 2026.
How has the price of KAITLIB FE 0.8-0.025 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has declined 42.5%. It has been tracked across 268 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for KAITLIB FE 0.8-0.025 MG CHEW TB?
Since May 12, 2021, the NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has ranged from a low of $0.9745 (Feb 21, 2024) to a high of $2.6953 (Oct 13, 2021), with a median of $1.7314 per EA.
Are there cheaper alternatives to KAITLIB FE 0.8-0.025 MG CHEW TB?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ALYACEN 1-35 28 TABLET, is $0.2063 per EA — about 84% below KAITLIB FE 0.8-0.025 MG CHEW TB.
Who manufactures KAITLIB FE 0.8-0.025 MG CHEW TB?
KAITLIB FE 0.8-0.025 MG CHEW TB (NDC 68180090373) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification